434 related articles for article (PubMed ID: 33562334)
1. Act Locally, Act Globally-Microbiota, Barriers, and Cytokines in Atherosclerosis.
Kurilenko N; Fatkhullina AR; Mazitova A; Koltsova EK
Cells; 2021 Feb; 10(2):. PubMed ID: 33562334
[TBL] [Abstract][Full Text] [Related]
2. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis.
Brandsma E; Kloosterhuis NJ; Koster M; Dekker DC; Gijbels MJJ; van der Velden S; Ríos-Morales M; van Faassen MJR; Loreti MG; de Bruin A; Fu J; Kuipers F; Bakker BM; Westerterp M; de Winther MPJ; Hofker MH; van de Sluis B; Koonen DPY
Circ Res; 2019 Jan; 124(1):94-100. PubMed ID: 30582442
[TBL] [Abstract][Full Text] [Related]
3. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.
Yeh CF; Chen YH; Liu SF; Kao HL; Wu MS; Yang KC; Wu WK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227973
[TBL] [Abstract][Full Text] [Related]
4. Microbiota-Mediated Immune Regulation in Atherosclerosis.
Eshghjoo S; Jayaraman A; Sun Y; Alaniz RC
Molecules; 2021 Jan; 26(1):. PubMed ID: 33401401
[TBL] [Abstract][Full Text] [Related]
5. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
Tedgui A; Mallat Z
Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
[TBL] [Abstract][Full Text] [Related]
6. Role of oral microbiota in atherosclerosis.
Liu XR; Xu Q; Xiao J; Deng YM; Tang ZH; Tang YL; Liu LS
Clin Chim Acta; 2020 Jul; 506():191-195. PubMed ID: 32220421
[TBL] [Abstract][Full Text] [Related]
7. Cytokines and Immune Responses in Murine Atherosclerosis.
Kusters PJ; Lutgens E
Methods Mol Biol; 2015; 1339():17-40. PubMed ID: 26445779
[TBL] [Abstract][Full Text] [Related]
8. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis.
Slocum C; Kramer C; Genco CA
J Intern Med; 2016 Jul; 280(1):114-28. PubMed ID: 26791914
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
McLaren JE; Michael DR; Ashlin TG; Ramji DP
Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia pneumoniae and atherosclerosis: the role of mast cells.
Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R
J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286
[TBL] [Abstract][Full Text] [Related]
12. Recent advances on the role of cytokines in atherosclerosis.
Ait-Oufella H; Taleb S; Mallat Z; Tedgui A
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):969-79. PubMed ID: 21508343
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of Th1 cells in atherosclerosis and its implications for therapy.
Chen J; Xiang X; Nie L; Guo X; Zhang F; Wen C; Xia Y; Mao L
Front Immunol; 2022; 13():1079668. PubMed ID: 36685487
[TBL] [Abstract][Full Text] [Related]
14. CD40 signaling in vascular cells: a key role in atherosclerosis?
Mach F; Schönbeck U; Libby P
Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L
Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321
[TBL] [Abstract][Full Text] [Related]
16. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.
Wolfs IM; Donners MM; de Winther MP
Thromb Haemost; 2011 Nov; 106(5):763-71. PubMed ID: 21947328
[TBL] [Abstract][Full Text] [Related]
17. The Role of Cytokines in the Development of Atherosclerosis.
Fatkhullina AR; Peshkova IO; Koltsova EK
Biochemistry (Mosc); 2016 Nov; 81(11):1358-1370. PubMed ID: 27914461
[TBL] [Abstract][Full Text] [Related]
18. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
19. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
20. A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases.
Gregersen I; Holm S; Dahl TB; Halvorsen B; Aukrust P
Expert Rev Cardiovasc Ther; 2016; 14(3):391-403. PubMed ID: 26641944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
